0000899243-17-012696.txt : 20170510 0000899243-17-012696.hdr.sgml : 20170510 20170510214614 ACCESSION NUMBER: 0000899243-17-012696 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170508 FILED AS OF DATE: 20170510 DATE AS OF CHANGE: 20170510 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMEDISYS INC CENTRAL INDEX KEY: 0000896262 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOME HEALTH CARE SERVICES [8082] IRS NUMBER: 113131700 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3854 AMERICAN WAY STREET 2: SUITE A CITY: BATON ROUGE STATE: LA ZIP: 70816 BUSINESS PHONE: 2252922031 MAIL ADDRESS: STREET 1: 3854 AMERICAN WAY STREET 2: SUITE A CITY: BATON ROUGE STATE: LA ZIP: 70816 FORMER COMPANY: FORMER CONFORMED NAME: ANALYTICAL NURSING MANAGEMENT CORP DATE OF NAME CHANGE: 19940819 FORMER COMPANY: FORMER CONFORMED NAME: M&N CAPITAL CORP DATE OF NAME CHANGE: 19930125 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pernosky Lawrence R CENTRAL INDEX KEY: 0001673555 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-24260 FILM NUMBER: 17832359 MAIL ADDRESS: STREET 1: 3854 AMERICAN WAY STREET 2: SUITE A CITY: BATON ROUGE STATE: LA ZIP: 70816 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-05-08 0 0000896262 AMEDISYS INC AMED 0001673555 Pernosky Lawrence R 3854 AMERICAN WAY, SUITE A BATON ROUGE LA 70816 0 1 0 0 Chief Human Resources Officer Common Stock 2017-05-08 4 M 0 8876 27.35 A 30093 D Common Stock 2017-05-08 4 S 0 12281 58.65 D 17812 D Common Stock 2017-05-09 4 M 0 11500 27.35 A 29312 D Common Stock 2017-05-09 4 S 0 10900 58.75 D 18412 D Common Stock 2017-05-09 4 S 0 600 59.25 D 17812 D Common Stock 2017-05-10 4 M 0 2124 27.35 A 19936 D Common Stock 2017-05-10 4 M 0 5626 27.35 A 25562 D Common Stock 2017-05-10 4 M 0 3750 27.35 A 29312 D Common Stock 2017-05-10 4 S 0 11300 58.99 D 18012 D Common Stock 2017-05-10 4 S 0 200 57.83 D 17812 D Common Stock 2017-05-08 4 S 0 214.9897 58.45 D 0 I Through 401(k) Plan Stock Option (Right to Buy) 27.35 2017-05-08 4 M 0 8876 0.00 D 2025-05-01 Common Stock 8876 36124 D Stock Option (Right to Buy) 27.35 2017-05-09 4 M 0 11500 0.00 D 2025-05-01 Common Stock 11500 24624 D Stock Option (Right to Buy) 27.35 2017-05-10 4 M 0 2124 0.00 D 2025-05-01 Common Stock 2124 22500 D Stock Option (Right to Buy) 27.35 2017-05-10 4 M 0 5626 0.00 D 2025-05-01 Common Stock 5626 5624 D Stock Option (Right to Buy) 27.35 2017-05-10 4 M 0 3750 0.00 D 2025-05-01 Common Stock 3750 7500 D The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.30 to $59.06, inclusive. The reporting person undertakes to provide to Amedisys, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4), and (5) to this Form 4. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.20 to $59.01, inclusive. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.22 to $59.29, inclusive. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.62 to $59.27, inclusive. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.70 to $57.96, inclusive. The reporting person was granted 45,000 time-based stock options (the "Time-Based Stock Options") on May 1, 2015. The Time-Based Stock Options are subject to time-based vesting conditions. The Time-Based Stock Options vested in equal, 25% installments on each of May 1, 2016 and May 1, 2017 and will vest in equal, 25% installments on each of May 1, 2018 and May 1, 2019, provided that the Reporting Person remains continuously employed by the Issuer on each such date, subject to pro-rated vesting provisions as provided in the award agreement for the Time-Based Stock Options. On May 1, 2015, the reporting person was granted 11,250 performance-based stock options (the "2015 Tranche Stock Options") that were subject to achievement of identified performance goals for fiscal year 2015, which the Compensation Committee of the Issuer's Board of Directors has certified as achieved. The 2015 Tranche Stock Options are subject to additional time-based vesting conditions (2,813 vested on May 1, 2016, 2,813 vested on May 1, 2017, 2,812 will vest on May 1, 2018 and 2,812 will vest on May 1, 2019), assuming the Reporting Person remains continuously employed by the Issuer on such date, subject to certain pro-rated vesting provisions as provided in the award agreement for the 2015 Tranche Stock Options. On May 1, 2015, the reporting person was granted 11,250 performance-based stock options (the "2016 Tranche Stock Options") that were subject to achievement of identified performance goals for fiscal year 2016, which the Compensation Committee of the Issuer's Board of Directors has certified as achieved. The 2016 Tranche Stock Options are subject to additional time-based vesting conditions (one-third vested on May 1, 2017, and one-third will vest on each of May 1, 2018 and May 1, 2019), assuming the Reporting Person remains continuously employed by the Issuer on such date, subject to certain pro-rated vesting provisions as provided in the award agreement for the 2016 Tranche Stock Options. /s/ David L. Kemmerly, pursuant to a power of attorney 2017-05-10